Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Silverback Asset Management is a U.S.-based SEC-registered investment adviser and hedge fund manager, not a life sciences, biotech, pharma, or healthcare operating company. Founded in 2002, the firm provides alternative investment and asset management services for institutional and qualified investors, with reported strategies including convertible arbitrage, capital structure arbitrage, and equity volatility arbitrage. Publicly available sources indicate the firm operates from Durham, North Carolina and manages private funds and separately managed accounts. Because it is a financial services firm rather than a drug developer or healthcare company, it does not have a therapeutic pipeline, product candidates, or clinical-stage programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Silverback Asset Management.